CEAP app for iPhone
CEAP classification app for vascular surgeons
PhleboCEAP is a CEAP classification app built for vascular surgeons who need fast, structured documentation of chronic venous disease, varicose veins, and related clinical diagnoses.
PhleboCEAP
A compact clinical workflow
Select CEAP sections, code the right and left legs separately, use templates, add severity scoring, and prepare the result for copying or iOS sharing.

CEAP-2020 coding without manual assembly
The app guides the surgeon through C, E, A, P, and L sections, so CEAP coding is assembled from structured choices rather than typed manually.
Bilateral documentation for Dxt and Sin
Right and left legs can be coded separately, which is important when venous disease is asymmetric or when one limb needs a different clinical description.
Templates for common venous scenarios
Preset CEAP scenarios help start from normal findings, phlebopathy, reticular varices, GSV or SSV varices, and other frequent patterns.
From classification to clinical text
PhleboCEAP connects CEAP-2020 classification, ICD-10 groups, and diagnosis wording so the final result is ready for documentation.
Frequently asked questions
Who is the CEAP classification app for?+
PhleboCEAP is designed for vascular surgeons and clinicians who document chronic venous disease and need a structured CEAP-2020 workflow on iPhone.
Does the app support ICD-10 diagnosis text?+
Yes. It supports clinical diagnosis wording with ICD-10 groups I83, I80, and I87 for venous disease scenarios.
Can PhleboCEAP be used before the App Store release?+
The landing page is prepared for release. The App Store link will be added when the app becomes available.
Keep CEAP coding close to the clinical workflow.
PhleboCEAP brings CEAP-2020 coding, ICD-10 diagnosis, SuperCEAP scoring, and sharing into one iPhone tool.
PhleboCEAP is a documentation aid for clinicians. It helps prepare CEAP codes and diagnosis wording, but it does not replace clinical judgment or the physician's responsibility for the final diagnosis.